Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis

NCT00869310 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

303

Enrollment

OTHER

Sponsor class

Stopped we terminated the study before enrolling 303/560 due to a slow accrual

Conditions

Emesis

Interventions

DRUG: aprepitant + dexamethasone
DRUG: metoclopramide + dexamethasone

Sponsor

S. Maria Hospital, Terni